Apellis Pharmaceuticals Stock Technical Analysis
| APLS Stock | USD 30.77 3.02 10.88% |
As of the 25th of November, Apellis Pharmaceuticals shows the risk adjusted performance of (0.06), and Mean Deviation of 2.39. Apellis Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apellis Pharmaceuticals market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Apellis Pharmaceuticals is priced correctly, providing market reflects its regular price of 30.77 per share. Given that Apellis Pharmaceuticals has information ratio of (0.13), we suggest you to validate Apellis Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.
Apellis Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Apellis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ApellisApellis |
Apellis Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 71.71 | Strong Buy | 21 | Odds |
Most Apellis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Apellis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Apellis Pharmaceuticals, talking to its executives and customers, or listening to Apellis conference calls.
Apellis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Apellis Pharmaceuticals Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Apellis Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Apellis Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Apellis Pharmaceuticals. You can use it to identify possible trend reversals for Apellis Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Apellis Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Apellis Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Apellis Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.18 , which may suggest that Apellis Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1250.53, which is the sum of squared deviations for the predicted Apellis Pharmaceuticals price change compared to its average price change.About Apellis Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Apellis Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Apellis Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Apellis Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Apellis Pharmaceuticals. By analyzing Apellis Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Apellis Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Apellis Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 55.4 | 37.39 | 190.0 | 199.5 | PTB Ratio | 20.09 | 32.3 | 36.52 | 19.3 |
Apellis Pharmaceuticals November 25, 2024 Technical Indicators
Most technical analysis of Apellis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Apellis from various momentum indicators to cycle indicators. When you analyze Apellis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 2.39 | |||
| Coefficient Of Variation | (1,111) | |||
| Standard Deviation | 3.41 | |||
| Variance | 11.62 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 15.97 | |||
| Value At Risk | (5.17) | |||
| Potential Upside | 4.31 | |||
| Skewness | 0.4109 | |||
| Kurtosis | 3.4 |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.